Everolimus versus sunitinib for patients with metastatic...

  • Main
  • 2016 / 1
  • Everolimus versus sunitinib for patients with metastatic...

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

Armstrong, Andrew J, Halabi, Susan, Eisen, Tim, Broderick, Samuel, Stadler, Walter M, Jones, Robert J, Garcia, Jorge A, Vaishampayan, Ulka N, Picus, Joel, Hawkins, Robert E, Hainsworth, John D, Kollma
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)00515-X
Date:
January, 2016
File:
PDF, 551 KB
english, 2016
Conversion to is in progress
Conversion to is failed